Pressure BioSciences Inc. (PBIO) and Cannaworx Inc. Announce Merger Targeting Markets with Massive Cumulative Value

  • The merged company will target the international cosmetics market (projected to reach $758 billion by 2025), agricultural technology and products ($729 billion by 2023), the biopharmaceuticals market ($389 billion by 2024) and the hemp-derived CBD market ($23.7 billion by 2023)
  • Cannaworx has a diverse portfolio and plans to launch several products in 2020, including two with a pain indication allowed under an FDA OTC monograph
  • Cannaworx’s sativa oil skincare serum sold $250K in 10 minutes on QVC in December 2019
  • Merger will give Cannaworx access to Pressure BioSciences’ proprietary method for processing oil-based products into high quality nanoemulsions (Ultra shear Technology), which is expected to further increase the bioavailability and efficacy of Cannaworx products

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology and biotherapeutics industry, announced that it has signed a binding letter of intent to acquire Cannaworx Inc., a privately-held company, according to a press release on April 29th (http://cnw.fm/f4ANi).

The merged entity, equipped with an extensive intellectual property portfolio utilizing a proprietary pressure platform, nanotechnology and advanced delivery systems, plans to disrupt a number of major world markets. These include the international cosmetics market, projected to reach $758 billion by…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://cnw.fm/PBIO

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

Leave a Reply